Synonyms: AC484
Compound class:
Synthetic organic
Comment: ABBV-CLS-484 is an orally bioavailable, active-site inhibitor of the protein tyrosine phosphatases PTPN1/N2 that was developed by AbbVie, Calico Life Sciences, and the Broad Institute of MIT and Harvard. Its chemical structure was first disclosed at the AACR spring meeting in 2022, and subsequently published in a Nature Communications article in mid-2023 [2]. ABBV-CLS-484-mediated inhibition of PTPN1/N2 in T cells promotes a potent immune-dependent anti-tumour effect[1].
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
Synonyms ![]() |
AC484 |
Database Links ![]() |
|
GtoPdb PubChem SID | 464244109 |
PubChem CID | 155103607 |
RCSB PDB Ligand | M5R |
Search Google for chemical match using the InChIKey | DVFCRTGTEXUFIN-GFCCVEGCSA-N |
Search Google for chemicals with the same backbone | DVFCRTGTEXUFIN |
UniChem Compound Search for chemical match using the InChIKey | DVFCRTGTEXUFIN-GFCCVEGCSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | DVFCRTGTEXUFIN-GFCCVEGCSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Osunprotafib (links to external site)
Cat. No. HY-145923 |